Bicycle Therapeutics PLC Sponsored ADR (BCYC) vs Oramed Pharmaceuticals Inc. (ORMP)
- Bicycle Therapeutics PLC Sponsored ADR BCYC 3.46 −3.89%
- Oramed Pharmaceuticals Inc. ORMP 4.07 −2.63%
Bicycle Therapeutics PLC Sponsored ADR and Oramed Pharmaceuticals Inc. are both Biotechnology companies. Bicycle Therapeutics PLC Sponsored ADR and Oramed Pharmaceuticals Inc. are of similar size ($181.4M and $173.9M). Bicycle Therapeutics PLC Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 1.0×. Oramed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 347.8% against 217.4%. Oramed Pharmaceuticals Inc. has the higher net margin (0.00% vs −311.1%) and the higher return on invested capital (−3.40% vs −64,747.5%). Across the 17 metrics below, Oramed Pharmaceuticals Inc. leads on 10 and Bicycle Therapeutics PLC Sponsored ADR on 7.
Valuation
Profitability
| Metric | BCYC | ORMP | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 32.31% | 65.16% |
| Operating margin | (343.60%) | 0.00% | 0.00% |
| Net margin | (311.11%) | 0.00% | 0.00% |
| Free cash flow margin | (340.29%) | 0.00% | 0.00% |
| Return on equity | (32.30%) | 73.90% | (56.36%) |
| Return on assets | (26.47%) | 65.52% | (48.04%) |
| Return on invested capital | (64,747.54%) | (3.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack